Blood Gas Analyzer Market - Global Forecast To 2030
商品番号 : SMB-89550
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年10月 |
| ページ数 | 281 |
| 図表数 | 359 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
血液ガス分析装置市場 – 製品（消耗品、サービス）、検査の種類（PoC、従来型）、サンプル（動脈血、静脈血、毛細血管血）、用途（呼吸器、救急医療管理）、エンドユーザー（病院、クリニック） – 2030年までの世界予測
市場規模は2025年に約27億米ドルと評価され、2030年には33億8000万米ドルに達すると予測されており、予測期間中は年平均成長率（CAGR）4.6%で成長します。病院や救命救急医療現場における迅速な患者評価の需要の高まり、リスクの高い患者における酸塩基平衡と酸素化の継続的なモニタリングの必要性、そして新興地域における医療費の増加により、市場は力強い成長を遂げています。さらに、病院の診断能力の向上と患者ケアの効率化に向けた政府の支援策も、世界中で血液ガス分析装置の導入を促進しています。
本調査レポートは、血液ガス分析装置市場を製品（消耗品、分析装置、サービス）、検査の種類（ポイントオブケア検査および従来型検査）、サンプルの種類（動脈血、静脈血、毛細血管血）、用途（救命救急管理、呼吸ケア、救急医療管理、その他の用途）、エンドユーザー（病院・ASC、クリニック、その他のエンドユーザー）、地域（北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ）別に分類しています。レポートは、血液ガス分析装置市場の成長に影響を与える推進要因、制約要因、機会、課題など、主要な要因に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析により、事業概要、ソリューション、主要戦略、買収・契約、製品・サービスの発売、そして血液ガス分析装置市場に関連する最近の動向に関する洞察を提供しています。本レポートは、血液ガス分析装置市場エコシステムにおける新興企業の競合分析も網羅しています。
本レポートは、血液ガス分析装置市場全体および各サブセグメントの収益数値の近似値に関する情報を提供し、市場リーダー企業および新規参入企業にとって役立ちます。本レポートは、ステークホルダーが競争環境を理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。また、本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、機会、課題に関する情報を提供するのにも役立ちます。
Report Description
The market was valued at approximately USD 2.70 billion in 2025 and is projected to reach USD 3.38 billion by 2030, growing at a CAGR of 4.6% during the forecast period. The market is witnessing strong growth due to the rising demand for rapid patient assessment in hospital and critical care settings, the need for continuous monitoring of acid-base balance and oxygenation in at-risk patients, and increasing healthcare spending in emerging regions. Additionally, supportive government initiatives to improve hospital diagnostic capabilities and streamline patient care further drive the adoption of blood gas analyzers worldwide.
The consumables segment accounted for the largest share of the blood gas analyzer market, by product in 2024.
The blood gas analyzer market is segmented into consumables, analyzers, and services based on product. In 2024, the consumables segment held the largest share of the market, as consumables are required for every test performed. The recurring demand for consumables in hospitals, ambulatory care settings, and clinics is a key factor driving the segment’s growth.
Hospitals & ASCs segment accounted for the largest share of the blood gas analyzer market, by end user in 2024.
The blood gas analyzer market is segmented by end user into Hospitals and ASCs, Clinics, and Other End Users. In 2024, Hospitals and ASCs accounted for the largest market share, as these facilities frequently test blood gas for critically ill patients and those undergoing complex procedures. The high patient volumes and the need for continuous monitoring in these settings drive substantial demand for blood gas analyzers.
Asia Pacific is expected to be the fastest-growing region in the blood gas analyzer market.
The global blood gas analyzer market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to experience the highest growth during the forecast period. Emerging economies in this region are seeing consistent GDP growth and a notable rise in disposable income, contributing to increased healthcare spending across a broader population base. Additional growth drivers include the rising incidence and prevalence of acute and chronic diseases, modernization of healthcare infrastructure, and the growing adoption of advanced diagnostic technologies, particularly in rural areas. These factors are anticipated to create substantial growth opportunities for blood gas analyzer companies in the Asia Pacific.
The breakup of the profile of primary participants in the blood gas analyzer market:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: C-level – 28%, D-level – 15%, and Others – 57%
- By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and Middle East & Africa- 4%
The key players in this market are Danaher Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Werfen S.A. (Spain), Nova Biomedical (US), Medica Corporation (US), Techno Medica Co., Ltd. (Japan), IDEXX Laboratories, Inc. (US), i-SENS, Inc. (South Korea), EDAN Instruments, Inc. (China), Guangzhou Wondfo Biotech Co., Ltd. (China), Labtron Equipment Ltd. (UK), Convergent Technologies GmbH & Co. KG (Germany), Erba Group (Czech Republic), ESCHWEILER GmbH & Co. KG (Germany), Sensa Core Medical Instrumentation Pvt. Ltd. (India), Chengdu Seamaty Technology Co., Ltd. (China), Labdex Ltd. (UK), Meizhou Cornley High-Tech Co., Ltd. (China), Paramedical Srl (Italy), Eaglenos Sciences, Inc. (China), B&E Bio-technology Co., Ltd. (US), Labnics Ltd. (UK) and Fison Instruments Ltd.(UK).
Research Coverage:
This research report categorizes the blood gas analyzer market by product (consumables, analyzers, and services), by type of testing (point-of-care testing and conventional testing), by sample type (arterial blood, venous blood, and capillary blood), by application (critical care management, respiratory care, emergency care management, and other applications), by end user (hospitals & ASCs, clinics, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the blood gas analyzer market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements, product & service launches, and recent developments associated with the blood gas analyzer market. This report covers a competitive analysis of upcoming startups in the blood gas analyzer market ecosystem.
Reasons to buy this report:
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall blood gas analyzer market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers, such as (rising incidence and prevalence of chronic and acute conditions, advancements in blood gas analyzer technology, inadequacy of alternative techniques, growing demand for point of care blood gas analyzers), opportunities (growth opportunities in developing countries, rising ICU and emergency department admissions), restraints (unfavorable reimbursement policies, complex operations and interpretation of data), and challenges (availability of refurbished analyzers, lack of data analysis software) influencing the growth of the blood gas analyzer market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the blood gas analyzer market
- Market Development: Comprehensive information about lucrative markets—the report analyzes the blood gas analyzer market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the blood gas analyzer market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Danaher Corporation (US), Werfen S.A. (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), and Siemens Healthineers AG (Germany), among others
Table of Contents
1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.3 STUDY SCOPE 29
1.3.1 MARKETS COVERED & REGIONAL SCOPE 29
1.3.2 INCLUSIONS & EXCLUSIONS 30
1.3.3 YEARS CONSIDERED 31
1.4 CURRENCY CONSIDERED 31
1.5 KEY STAKEHOLDERS 31
1.6 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
2.2 RESEARCH APPROACH 33
2.2.1 SECONDARY DATA 34
2.2.1.1 Key secondary sources 34
2.2.1.2 Key data from secondary sources 35
2.2.2 PRIMARY DATA 36
2.2.2.1 Primary sources 36
2.2.2.2 Key data from primary sources 37
2.2.2.3 Key industry insights 38
2.2.2.4 Breakdown of primary interviews 38
2.3 MARKET SIZE ESTIMATION 39
2.3.1 BOTTOM-UP APPROACH 40
2.3.1.1 Approach 1: Company revenue estimation approach 40
2.3.1.2 Approach 2: Presentations of companies and primary interviews 40
2.3.1.3 Growth forecast 41
2.3.1.4 CAGR projections 41
2.3.2 TOP-DOWN APPROACH 41
2.4 DATA TRIANGULATION 43
2.5 MARKET SHARE ASSESSMENT 44
2.6 RESEARCH ASSUMPTIONS 44
2.6.1 PARAMETRIC ASSUMPTIONS 44
2.7 RESEARCH LIMITATIONS 44
2.8 RISK ASSESSMENT 45
3 EXECUTIVE SUMMARY 46
4 PREMIUM INSIGHTS 51
4.1 BLOOD GAS ANALYZERS MARKET OVERVIEW 51
4.2 BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2025 VS. 2030 (USD MILLION) 52
4.3 BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2025 VS. 2030 (USD MILLION) 52
4.4 BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2025 VS. 2030 (USD MILLION) 53
4.5 BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 53
4.6 BLOOD GAS ANALYZERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 54
4.7 BLOOD GAS ANALYZERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
5.2.1 DRIVERS 56
5.2.1.1 Rising incidence and prevalence of chronic and acute conditions 56
5.2.1.2 Advancements in blood gas analyzer technology 57
5.2.1.3 Inadequacy of alternative techniques 58
5.2.1.4 Growing demand for point-of-care blood gas analyzers 58
5.2.2 RESTRAINTS 58
5.2.2.1 Unfavorable reimbursement policies 58
5.2.2.2 Complex operations & interpretation of data 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Growth opportunities in developing countries 59
5.2.3.2 Rising ICU and emergency department admissions 60
5.2.4 CHALLENGES 61
5.2.4.1 Availability of refurbished analyzers 61
5.2.4.2 Lack of data analysis software 61
5.3 PRICING ANALYSIS 61
5.3.1 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS, 2023–2025 61
5.3.2 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS,
BY KEY PLAYER, 2023−2025 62
5.3.3 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS,
BY REGION, 2023−2025 63
5.4 PATENT ANALYSIS 64
5.4.1 LIST OF MAJOR PATENTS 65
5.5 VALUE CHAIN ANALYSIS 66
5.6 SUPPLY CHAIN ANALYSIS 67
5.7 TRADE ANALYSIS 68
5.7.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPARATUS
FOR PHYSICAL OR CHEMICAL ANALYSIS 68
5.7.2 IMPORT DATA (HS CODE 9027) 69
5.7.3 EXPORT DATA (HS CODE 9027) 69
5.8 ECOSYSTEM ANALYSIS 70
5.8.1 BLOOD GAS ANALYZERS MARKET: ROLE IN ECOSYSTEM 70
5.9 PORTER’S FIVE FORCES ANALYSIS 71
5.9.1 THREAT OF NEW ENTRANTS 72
5.9.2 THREAT OF SUBSTITUTES 72
5.9.3 BARGAINING POWER OF BUYERS 73
5.9.4 BARGAINING POWER OF SUPPLIERS 73
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 73
5.10 REGULATORY ANALYSIS 73
5.10.1 REGULATORY LANDSCAPE 73
5.10.1.1 North America 73
5.10.1.1.1 US 73
5.10.1.1.2 Canada 73
5.10.1.2 Europe 74
5.10.1.2.1 Germany 74
5.10.1.2.2 UK 75
5.10.1.2.3 France 75
5.10.1.2.4 Italy 75
5.10.1.3 Asia Pacific 75
5.10.1.3.1 China 75
5.10.1.3.2 Japan 76
5.10.1.3.3 India 76
5.10.1.4 Latin America 76
5.10.1.4.1 Brazil 77
5.10.1.4.2 Mexico 77
5.10.1.5 Middle East 77
5.10.1.6 Africa 77
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 78
5.11 TECHNOLOGY ANALYSIS 79
5.11.1 KEY TECHNOLOGIES 80
5.11.1.1 Electrochemical sensors 80
5.11.2 COMPLEMENTARY TECHNOLOGIES 80
5.11.2.1 Optical sensors 80
5.11.3 ADJACENT TECHNOLOGIES 80
5.11.3.1 Microfluidics 80
5.12 KEY CONFERENCES & EVENTS, 2025–2026 81
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 82
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
5.14.2 BUYING CRITERIA 83
5.15 INVESTMENT & FUNDING SCENARIO 84
5.16 CASE STUDY ANALYSIS 85
5.16.1 CASE STUDY 1: ROLE OF BLOOD GAS ANALYSIS IN EMERGENCY
AND CRITICAL CARE 85
5.16.2 CASE STUDY 2: EVALUATION OF A HANDHELD BLOOD GAS
ANALYZER IN INTENSIVE CARE SETTINGS 85
5.16.3 CASE STUDY 3: ROLE OF QUALITY MANAGEMENT SYSTEMS
IN BLOOD GAS ANALYSIS 86
5.17 IMPACT OF AI/GENERATIVE AI ON BLOOD GAS ANALYZERS MARKET 86
5.17.1 INTRODUCTION 86
5.17.2 MARKET POTENTIAL OF AI 87
5.17.3 AI USE CASES 87
5.17.4 IMPLEMENTATION OF AI, BY KEY COMPANY & CASE 88
5.17.5 FUTURE OF AI IN BLOOD GAS ANALYZERS MARKET 89
5.18 IMPACT OF 2025 US TARIFFS ON BLOOD GAS ANALYZERS MARKET 89
5.18.1 INTRODUCTION 89
5.18.2 KEY TARIFF RATES 89
5.18.3 PRICE IMPACT ANALYSIS 90
5.18.4 KEY IMPACT ON COUNTRY/REGION 90
5.18.4.1 North America 90
5.18.4.2 Europe 91
5.18.4.3 Asia Pacific 91
5.18.5 IMPACT ON END-USE INDUSTRIES 91
5.18.5.1 Hospitals & ASCs 91
5.18.5.2 Clinics 91
6 BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE 92
6.1 INTRODUCTION 93
6.2 CONSUMABLES 93
6.2.1 RECURRING USE OF CONSUMABLES TO DRIVE MARKET GROWTH 93
6.3 ANALYZERS 97
6.3.1 TECHNOLOGICAL ADVANCEMENTS IN ANALYZERS TO DRIVE ADOPTION 97
6.4 SERVICES 101
6.4.1 INCREASING FOCUS ON OPERATIONAL EFFICIENCY
TO PROPEL MARKET EXPANSION 101
7 BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING 105
7.1 INTRODUCTION 106
7.2 POINT-OF-CARE TESTING 106
7.2.1 IMPROVED USABILITY AND INNOVATIONS IN POC ANALYZERS
TO BOOST ADOPTION OF POINT-OF-CARE TESTING 106
7.3 CONVENTIONAL TESTING 109
7.3.1 GROWING FOCUS ON AUTOMATION AND ACCURACY
TO STRENGTHEN MARKET GROWTH 109
8 BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE 113
8.1 INTRODUCTION 114
8.2 ARTERIAL BLOOD 114
8.2.1 HIGH UTILIZATION IN CRITICAL CARE SETTINGS
TO SUPPORT MARKET GROWTH 114
8.3 VENOUS BLOOD 117
8.3.1 REDUCED INVASIVENESS OF VENOUS BLOOD SAMPLING
TO BOOST MARKET ADOPTION 117
8.4 CAPILLARY BLOOD 120
8.4.1 RISING DEMAND FOR PATIENT-CENTRIC CAPILLARY SAMPLING
TO DRIVE MARKET EXPANSION 120
9 BLOOD GAS ANALYZERS MARKET, BY APPLICATION 124
9.1 INTRODUCTION 125
9.2 CRITICAL CARE MANAGEMENT 125
9.2.1 INCREASING BURDEN OF ACUTE CRITICAL ILLNESSES
TO SUPPORT MARKET EXPANSION 125
9.3 RESPIRATORY CARE 128
9.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES
TO DRIVE MARKET GROWTH 128
9.4 EMERGENCY CARE MANAGEMENT 131
9.4.1 INCREASING EMERGENCY DEPARTMENT VISITS TO PROPEL
DEMAND FOR BLOOD GAS ANALYZERS 131
9.5 OTHER APPLICATIONS 134
10 BLOOD GAS ANALYZERS MARKET, BY END USER 138
10.1 INTRODUCTION 139
10.2 HOSPITALS & ASCS 139
10.2.1 EXPANDING HEALTHCARE INFRASTRUCTURE TO SPEED UP MARKET GROWTH 139
10.3 CLINICS 142
10.3.1 GROWING USE OF POINT-OF-CARE BLOOD GAS ANALYZERS
TO SUPPORT MARKET GROWTH 142
10.4 OTHER END USERS 145
11 BLOOD GAS ANALYZERS MARKET, BY REGION 149
11.1 INTRODUCTION 150
11.2 NORTH AMERICA 150
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 154
11.2.2 US 154
11.2.2.1 Increasing prevalence of chronic & respiratory diseases to drive market 154
11.2.3 CANADA 157
11.2.3.1 Rising demand for real-time diagnostics tools to drive market growth 157
11.3 EUROPE 160
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 163
11.3.2 GERMANY 163
11.3.2.1 Favorable government policies to propel market growth 163
11.3.3 UK 165
11.3.3.1 Rising emergency department visits to drive market growth 165
11.3.4 FRANCE 168
11.3.4.1 Enhanced healthcare policies and strategic investments in diagnostics to boost market growth 168
11.3.5 ITALY 170
11.3.5.1 Growing chronic disease incidence and government initiatives to boost Italy’s blood gas analyzers market 170
11.3.6 SPAIN 172
11.3.6.1 Growing public health initiatives to augment market growth 172
11.3.7 REST OF EUROPE 175
11.4 ASIA PACIFIC 177
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 181
11.4.2 CHINA 181
11.4.2.1 Healthcare infrastructure development and disease burden to support market 181
11.4.3 JAPAN 183
11.4.3.1 Well-developed healthcare system and high geriatric population to aid market growth 183
11.4.4 INDIA 185
11.4.4.1 Initiatives to enhance access to healthcare and improve infrastructure to propel market growth 185
11.4.5 REST OF ASIA PACIFIC 188
11.5 LATIN AMERICA 190
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 193
11.5.2 BRAZIL 193
11.5.2.1 Universal healthcare access to drive adoption in Brazil 193
11.5.3 MEXICO 195
11.5.3.1 Rising medical tourism to create strong demand for advanced diagnostic solutions 195
11.5.4 REST OF LATIN AMERICA 198
11.6 MIDDLE EAST & AFRICA 200
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 203
11.6.2 KINGDOM OF SAUDI ARABIA 203
11.6.2.1 Rising government healthcare expenditure to boost market 203
11.6.3 UAE 206
11.6.3.1 Improvements in healthcare infrastructure to support growth 206
11.6.4 REST OF MIDDLE EAST & AFRICA 208
12 COMPETITIVE LANDSCAPE 211
12.1 INTRODUCTION 211
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 211
12.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN BLOOD GAS ANALYZERS MARKET 212
12.3 REVENUE ANALYSIS, 2020–2024 214
12.4 MARKET SHARE ANALYSIS, 2024 215
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 217
12.5.1 STARS 217
12.5.2 EMERGING LEADERS 217
12.5.3 PERVASIVE PLAYERS 217
12.5.4 PARTICIPANTS 217
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 219
12.5.5.1 Company footprint 219
12.5.5.2 Region footprint 220
12.5.5.3 Product & service footprint 220
12.5.5.4 Type of testing footprint 221
12.5.5.5 Sample type footprint 221
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 222
12.6.1 PROGRESSIVE COMPANIES 222
12.6.2 RESPONSIVE COMPANIES 222
12.6.3 DYNAMIC COMPANIES 222
12.6.4 STARTING BLOCKS 222
12.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 224
12.6.5.1 Detailed list of key startups/SMEs 224
12.6.5.2 Competitive benchmarking of startups/SMEs (1/2) 224
12.6.5.3 Competitive benchmarking of startups/SMEs (2/2) 225
12.7 COMPANY VALUATION & FINANCIAL METRICS 225
12.7.1 FINANCIAL METRICS 225
12.7.2 COMPANY VALUATION 226
12.8 BRAND/PRODUCT COMPARISON 226
12.9 COMPETITIVE SCENARIO 227
12.9.1 PRODUCT/SERVICE LAUNCHES 227
12.9.2 DEALS 228
12.9.3 EXPANSIONS 229
13 COMPANY PROFILES 230
13.1 KEY PLAYERS 230
13.1.1 DANAHER CORPORATION 230
13.1.1.1 Business overview 230
13.1.1.2 Products/Services offered 232
13.1.1.3 Recent developments 232
13.1.1.3.1 Deals 232
13.1.1.4 MnM view 233
13.1.1.4.1 Key strengths 233
13.1.1.4.2 Strategic choices 233
13.1.1.4.3 Weaknesses & competitive threats 233
13.1.2 WERFEN S.A. 234
13.1.2.1 Business overview 234
13.1.2.2 Products/Services offered 235
13.1.2.3 Recent developments 236
13.1.2.3.1 Product/Service launches 236
13.1.2.3.2 Expansions 236
13.1.2.4 MnM view 236
13.1.2.4.1 Key strengths 236
13.1.2.4.2 Strategic choices 237
13.1.2.4.3 Weaknesses & competitive threats 237
13.1.3 SIEMENS HEALTHINEERS AG 238
13.1.3.1 Business overview 238
13.1.3.2 Products/Services offered 240
13.1.3.3 Recent developments 240
13.1.3.3.1 Deals 240
13.1.3.3.2 Expansions 241
13.1.3.4 MnM view 241
13.1.3.4.1 Key strengths 241
13.1.3.4.2 Strategic choices 241
13.1.3.4.3 Weaknesses & competitive threats 241
13.1.4 F. HOFFMANN-LA ROCHE LTD. 242
13.1.4.1 Business overview 242
13.1.4.2 Products/Services offered 243
13.1.4.3 Recent developments 244
13.1.4.3.1 Expansions 244
13.1.4.4 MnM view 244
13.1.4.4.1 Key strengths 244
13.1.4.4.2 Strategic choices 244
13.1.4.4.3 Weaknesses & competitive threats 244
13.1.5 ABBOTT LABORATORIES 245
13.1.5.1 Business overview 245
13.1.5.2 Products/Services offered 246
13.1.5.3 MnM view 247
13.1.5.3.1 Key strengths 247
13.1.5.3.2 Strategic choices 247
13.1.5.3.3 Weaknesses & competitive threats 247
13.1.6 NOVA BIOMEDICAL 248
13.1.6.1 Business overview 248
13.1.6.2 Products/Services offered 249
13.1.6.3 Recent developments 249
13.1.6.3.1 Product/Service launches 249
13.1.6.3.2 Deals 250
13.1.6.3.3 Expansions 250
13.1.7 MEDICA CORPORATION 251
13.1.7.1 Business overview 251
13.1.7.2 Products/Services offered 251
13.1.8 TECHNO MEDICA CO., LTD. 252
13.1.8.1 Business overview 252
13.1.8.2 Products/Services offered 253
13.1.9 IDEXX LABORATORIES, INC. 254
13.1.9.1 Business overview 254
13.1.9.2 Products/Services offered 255
13.1.10 I-SENS, INC. 256
13.1.10.1 Business overview 256
13.1.10.2 Products/Services offered 257
13.2 OTHER PLAYERS 258
13.2.1 EDAN INSTRUMENTS, INC. 258
13.2.2 GUANGZHOU WONDFO BIOTECH CO., LTD. 259
13.2.3 LABTRON EQUIPMENT LTD. 260
13.2.4 CONVERGENT TECHNOLOGIES GMBH & CO. KG 261
13.2.5 ERBA GROUP 262
13.2.6 ESCHWEILER GMBH & CO.KG 263
13.2.7 SENSA CORE MEDICAL INSTRUMENTATION PVT. LTD. 264
13.2.8 CHENGDU SEAMATY TECHNOLOGY CO., LTD. 265
13.2.9 LABDEX LTD. 266
13.2.10 MEIZHOU CORNLEY HIGH-TECH CO., LTD. 267
13.2.11 PARAMEDICAL SRL 268
13.2.12 EAGLENOS SCIENCES, INC. 269
13.2.13 B&E BIO-TECHNOLOGY CO., LTD. 270
13.2.14 LABNICS LTD. 271
13.2.15 FISON INSTRUMENTS LTD. 272
14 APPENDIX 273
14.1 DISCUSSION GUIDE 273
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 277
14.3 CUSTOMIZATION OPTIONS 279
14.4 RELATED REPORTS 279
14.5 AUTHOR DETAILS 280
LIST OF TABLES
TABLE 1 BLOOD GAS ANALYZERS MARKET: INCLUSIONS & EXCLUSIONS 30
TABLE 2 BLOOD GAS ANALYZERS MARKET: KEY DATA FROM PRIMARY SOURCES 37
TABLE 3 AVERAGE SELLING PRICING TREND OF BLOOD GAS BY PRODUCT AFTER ANALYZER, 2023–2025 62
TABLE 4 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS,
BY KEY PLAYER, 2023–2025 62
TABLE 5 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS, BY REGION,
2023–2025 63
TABLE 6 LIST OF MAJOR PATENTS, 2023–2025 65
TABLE 7 IMPORT DATA FOR INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE 9027), BY COUNTRY, 2020–2024 (USD MILLION) 69
TABLE 8 EXPORT DATA FOR INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE 9027), BY COUNTRY, 2020–2024 (USD MILLION) 69
TABLE 9 BLOOD GAS ANALYZERS MARKET: ROLE IN ECOSYSTEM 70
TABLE 11 CLASSIFICATION OF IVD DEVICES IN EUROPE 74
TABLE 12 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN 76
TABLE 15 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 78
TABLE 18 BLOOD GAS ANALYZERS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 81
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF
BLOOD GAS ANALYZERS (%) 83
TABLE 20 KEY BUYING CRITERIA FOR BLOOD GAS ANALYZERS 84
TABLE 21 KEY COMPANIES IMPLEMENTING AI 88
TABLE 22 US-ADJUSTED RECIPROCAL TARIFF RATES 89
TABLE 23 BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 93
TABLE 24 CONSUMABLES OFFERED BY KEY MARKET PLAYERS 94
TABLE 25 BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY REGION,
2023–2030 (USD MILLION) 95
TABLE 26 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES,
BY COUNTRY, 2023–2030 (USD MILLION) 95
TABLE 27 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 96
TABLE 28 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION) 96
TABLE 29 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES,
BY COUNTRY, 2023–2030 (USD MILLION) 97
TABLE 30 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES,
BY COUNTRY, 2023–2030 (USD MILLION) 97
TABLE 31 ANALYZERS OFFERED BY KEY MARKET PLAYERS 98
TABLE 32 BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY REGION,
2023–2030 (USD MILLION) 99
TABLE 33 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS,
BY COUNTRY, 2023–2030 (USD MILLION) 99
TABLE 34 EUROPE: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY,
2023–2030 (USD MILLION) 100
TABLE 35 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 36 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 37 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS,
BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 38 BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY REGION,
2023–2030 (USD MILLION) 102
TABLE 39 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 102
TABLE 40 EUROPE: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY,
2023–2030 (USD MILLION) 103
TABLE 41 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 103
TABLE 42 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 43 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR SERVICES,
BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 44 BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 106
TABLE 45 KEY POINT-OF-CARE TESTING DEVICES AVAILABLE IN MARKET 107
TABLE 46 BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY REGION, 2023–2030 (USD MILLION) 107
TABLE 47 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 48 EUROPE: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING,
BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 49 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING,
BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 50 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 51 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 52 KEY CONVENTIONAL TESTING DEVICES AVAILABLE IN MARKET 110
TABLE 53 BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY REGION, 2023–2030 (USD MILLION) 110
TABLE 54 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 55 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING,
BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 56 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING,
BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 57 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 112
TABLE 58 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 112
TABLE 59 BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 114
TABLE 60 SOME ARTERIAL BLOOD-BASED PRODUCTS AVAILABLE IN MARKET 115
TABLE 61 BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY REGION, 2023–2030 (USD MILLION) 115
TABLE 62 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 63 EUROPE: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES,
BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 64 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 65 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 66 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL
BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 67 SOME VENOUS BLOOD-BASED PRODUCTS AVAILABLE IN MARKET 118
TABLE 68 BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY REGION, 2023–2030 (USD MILLION) 118
TABLE 69 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 70 EUROPE: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES,
BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 71 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES,
BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 72 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 120
TABLE 73 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 120
TABLE 74 SOME CAPILLARY BLOOD-BASED PRODUCTS AVAILABLE IN MARKET 121
TABLE 75 BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY REGION, 2023–2030 (USD MILLION) 121
TABLE 76 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 77 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES,
BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 78 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 79 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 80 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 81 BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 125
TABLE 82 BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 126
TABLE 83 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 84 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT,
BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 85 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 127
TABLE 86 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 87 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 88 BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY REGION,
2023–2030 (USD MILLION) 129
TABLE 89 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE,
BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 90 EUROPE: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 91 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE,
BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 92 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE,
BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 93 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 94 BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT,
BY REGION, 2023–2030 (USD MILLION) 132
TABLE 95 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 96 EUROPE: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 97 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 98 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 99 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 100 BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY REGION,
2023–2030 (USD MILLION) 135
TABLE 101 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 102 EUROPE: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 103 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 104 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 105 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 106 BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 139
TABLE 107 BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY REGION,
2023–2030 (USD MILLION) 140
TABLE 108 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS,
BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 109 EUROPE: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 110 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS,
BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 111 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS,
BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 112 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 113 BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY REGION,
2023–2030 (USD MILLION) 143
TABLE 114 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 143
TABLE 115 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY,
2023–2030 (USD MILLION) 144
TABLE 116 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY,
2023–2030 (USD MILLION) 144
TABLE 117 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 118 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CLINICS,
BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 119 BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 146
TABLE 120 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 121 EUROPE: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 122 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 123 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 124 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR
OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 125 BLOOD GAS ANALYZERS MARKET, BY REGION, 2023–2030 (USD MILLION) 150
TABLE 126 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 152
TABLE 127 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 152
TABLE 128 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 152
TABLE 129 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 153
TABLE 130 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 153
TABLE 131 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 153
TABLE 132 NORTH AMERICA: MACROECONOMIC INDICATORS 154
TABLE 133 US: NUMBER OF EMERGENCY DEPARTMENT VISITS, 2023–2030 155
TABLE 134 US: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 156
TABLE 135 US: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 156
TABLE 136 US: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 156
TABLE 137 US: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 157
TABLE 138 US: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 157
TABLE 139 CANADA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 158
TABLE 140 CANADA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 158
TABLE 141 CANADA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 159
TABLE 142 CANADA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 159
TABLE 143 CANADA: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 159
TABLE 144 EUROPE: BLOOD GAS ANALYZERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 160
TABLE 145 EUROPE: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 161
TABLE 146 EUROPE: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 161
TABLE 147 EUROPE: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 161
TABLE 148 EUROPE: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 162
TABLE 149 EUROPE: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 162
TABLE 150 EUROPE: MACROECONOMIC INDICATORS 162
TABLE 151 GERMANY: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 164
TABLE 152 GERMANY: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 164
TABLE 153 GERMANY: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 164
TABLE 154 GERMANY: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 165
TABLE 155 GERMANY: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 165
TABLE 156 UK: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 166
TABLE 157 UK: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 166
TABLE 158 UK: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 167
TABLE 159 UK: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 167
TABLE 160 UK: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 167
TABLE 161 FRANCE: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 168
TABLE 162 FRANCE: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 169
TABLE 163 FRANCE: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 169
TABLE 164 FRANCE: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 169
TABLE 165 FRANCE: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 170
TABLE 166 ITALY: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 171
TABLE 167 ITALY: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 171
TABLE 168 ITALY: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 171
TABLE 169 ITALY: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 172
TABLE 170 ITALY: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 172
TABLE 171 SPAIN: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 173
TABLE 172 SPAIN: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 173
TABLE 173 SPAIN: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 174
TABLE 174 SPAIN: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 174
TABLE 175 SPAIN: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 174
TABLE 176 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 175
TABLE 177 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 176
TABLE 178 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 176
TABLE 179 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 176
TABLE 180 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 177
TABLE 181 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 178
TABLE 182 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 179
TABLE 183 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 179
TABLE 184 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 179
TABLE 185 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 180
TABLE 186 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 180
TABLE 187 ASIA PACIFIC: MACROECONOMIC INDICATORS 180
TABLE 188 CHINA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 182
TABLE 189 CHINA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 182
TABLE 190 CHINA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 182
TABLE 191 CHINA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 183
TABLE 192 CHINA: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 183
TABLE 193 JAPAN: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 184
TABLE 194 JAPAN: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 184
TABLE 195 JAPAN: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 184
TABLE 196 JAPAN: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 185
TABLE 197 JAPAN: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 185
TABLE 198 INDIA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 186
TABLE 199 INDIA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 186
TABLE 200 INDIA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 187
TABLE 201 INDIA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 187
TABLE 202 INDIA: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 187
TABLE 203 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 188
TABLE 204 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 189
TABLE 205 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 189
TABLE 206 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 189
TABLE 207 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 190
TABLE 208 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 191
TABLE 209 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 191
TABLE 210 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 191
TABLE 211 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 192
TABLE 212 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 192
TABLE 213 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 192
TABLE 214 LATIN AMERICA: MACROECONOMIC INDICATORS 193
TABLE 215 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 194
TABLE 216 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 194
TABLE 217 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 194
TABLE 218 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 195
TABLE 219 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 195
TABLE 220 MEXICO: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 196
TABLE 221 MEXICO: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 196
TABLE 222 MEXICO: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 197
TABLE 223 MEXICO: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 197
TABLE 224 MEXICO: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 197
TABLE 225 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 198
TABLE 226 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 199
TABLE 227 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 199
TABLE 228 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 199
TABLE 229 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 200
TABLE 230 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 201
TABLE 231 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 201
TABLE 232 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 201
TABLE 233 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 202
TABLE 234 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 202
TABLE 235 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY END USER,
2023–2030 (USD MILLION) 202
TABLE 236 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 203
TABLE 237 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 204
TABLE 238 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023–2030 (USD MILLION) 204
TABLE 239 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 205
TABLE 240 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 205
TABLE 241 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 205
TABLE 242 UAE: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 206
TABLE 243 UAE: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2023–2030 (USD MILLION) 206
TABLE 244 UAE: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2023–2030 (USD MILLION) 207
TABLE 245 UAE: BLOOD GAS ANALYZERS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 207
TABLE 246 UAE: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023–2030 (USD MILLION) 207
TABLE 247 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 208
TABLE 248 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET,
BY TYPE OF TESTING, 2023–2030 (USD MILLION) 209
TABLE 249 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET,
BY SAMPLE TYPE, 2023–2030 (USD MILLION) 209
TABLE 250 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 209
TABLE 251 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET,
BY END USER, 2023–2030 (USD MILLION) 210
TABLE 252 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN BLOOD GAS ANALYZERS MARKET, JANUARY 2022−SEPTEMBER 2025 212
TABLE 253 BLOOD GAS ANALYZERS MARKET: DEGREE OF COMPETITION 215
TABLE 254 BLOOD GAS ANALYZERS MARKET: REGION FOOTPRINT 220
TABLE 255 BLOOD GAS ANALYZERS MARKET: PRODUCT & SERVICE FOOTPRINT 220
TABLE 256 BLOOD GAS ANALYZERS MARKET: TYPE OF TESTING FOOTPRINT 221
TABLE 257 BLOOD GAS ANALYZERS MARKET: SAMPLE TYPE FOOTPRINT 221
TABLE 258 BLOOD GAS ANALYZERS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 224
TABLE 259 BLOOD GAS ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2) 224
TABLE 260 BLOOD GAS ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2) 225
TABLE 261 BLOOD GAS ANALYZERS MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–SEPTEMBER 2025 227
TABLE 262 BLOOD GAS ANALYZERS MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025 228
TABLE 263 BLOOD GAS ANALYZERS MARKET: EXPANSIONS,
JANUARY 2022–SEPTEMBER 2025 229
TABLE 264 DANAHER CORPORATION: COMPANY OVERVIEW 230
TABLE 265 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 232
TABLE 266 DANAHER CORPORATION: DEALS, JANUARY 2022–SEPTEMBER 2025 232
TABLE 267 WERFEN S.A.: COMPANY OVERVIEW 234
TABLE 268 WERFEN S.A.: PRODUCTS/SERVICES OFFERED 235
TABLE 269 WERFEN S.A.: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–SEPTEMBER 2025 236
TABLE 270 WERFEN S.A.: EXPANSIONS, JANUARY 2022−SEPTEMBER 2025 236
TABLE 271 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 238
TABLE 272 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED 240
TABLE 273 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–SEPTEMBER 2025 240
TABLE 274 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022−SEPTEMBER 2025 241
TABLE 275 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 242
TABLE 276 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED 243
TABLE 277 F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 244
TABLE 278 ABBOTT LABORATORIES: COMPANY OVERVIEW 245
TABLE 279 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED 246
TABLE 280 NOVA BIOMEDICAL: COMPANY OVERVIEW 248
TABLE 281 NOVA BIOMEDICAL: PRODUCTS/SERVICES OFFERED 249
TABLE 282 NOVA BIOMEDICAL: PRODUCT/SERVICE LAUNCHES,
JANUARY 2022–SEPTEMBER 2025 249
TABLE 283 NOVA BIOMEDICAL: DEALS, JANUARY 2022–SEPTEMBER 2025 250
TABLE 284 NOVA BIOMEDICAL: EXPANSIONS, JANUARY 2022−SEPTEMBER 2025 250
TABLE 285 MEDICA CORPORATION: COMPANY OVERVIEW 251
TABLE 286 MEDICA CORPORATION: PRODUCTS/SERVICES OFFERED 251
TABLE 287 TECHNO MEDICA CO., LTD.: COMPANY OVERVIEW 252
TABLE 288 TECHNO MEDICA CO., LTD.: PRODUCTS/SERVICES OFFERED 253
TABLE 289 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW 254
TABLE 290 IDEXX LABORATORIES, INC: PRODUCTS/SERVICES OFFERED 255
TABLE 291 I-SENS, INC.: COMPANY OVERVIEW 256
TABLE 292 I-SENS, INC.: PRODUCTS/SERVICES OFFERED 257
TABLE 293 EDAN INSTRUMENTS, INC.: COMPANY OVERVIEW 258
TABLE 294 GUANGZHOU WONDFO BIOTECH CO., LTD.: COMPANY OVERVIEW 259
TABLE 295 LABTRON EQUIPMENT LTD.: COMPANY OVERVIEW 260
TABLE 296 CONVERGENT TECHNOLOGIES GMBH & CO. KG: COMPANY OVERVIEW 261
TABLE 297 ERBA GROUP: COMPANY OVERVIEW 262
TABLE 298 ESCHWEILER GMBH & CO.KG: COMPANY OVERVIEW 263
TABLE 299 SENSA CORE MEDICAL INSTRUMENTATION PVT. LTD.: COMPANY OVERVIEW 264
TABLE 300 CHENGDU SEAMATY TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 265
TABLE 301 LABDEX LTD.: COMPANY OVERVIEW 266
TABLE 302 MEIZHOU CORNLEY HIGH-TECH CO., LTD.: COMPANY OVERVIEW 267
TABLE 303 PARAMEDICAL SRL: COMPANY OVERVIEW 268
TABLE 304 EAGLENOS SCIENCES, INC.: COMPANY OVERVIEW 269
TABLE 305 B&E BIO-TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 270
TABLE 306 LABNICS LTD.: COMPANY OVERVIEW 271
TABLE 307 FISON INSTRUMENTS LTD.: COMPANY OVERVIEW 272
LIST OF FIGURES
FIGURE 1 BLOOD GAS ANALYZERS MARKET SEGMENTATION & REGIONAL SCOPE 29
FIGURE 2 BLOOD GAS ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY 33
FIGURE 3 PRIMARY SOURCES 36
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE
AND DEMAND-SIDE PARTICIPANTS 38
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 39
FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 40
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41
FIGURE 8 BLOOD GAS ANALYZERS MARKET: TOP-DOWN APPROACH 42
FIGURE 9 DATA TRIANGULATION METHODOLOGY 43
FIGURE 10 BLOOD GAS ANALYZERS MARKET: RESEARCH ASSUMPTIONS 44
FIGURE 11 BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE,
2025 VS. 2030 (USD MILLION) 46
FIGURE 12 BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING,
2025 VS. 2030 (USD MILLION) 47
FIGURE 13 BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE,
2025 VS. 2030 (USD MILLION) 47
FIGURE 14 BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 48
FIGURE 15 BLOOD GAS ANALYZERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 49
FIGURE 16 BLOOD GAS ANALYZERS MARKET, BY REGION, 2025 VS. 2030 (USD MILLION) 49
FIGURE 17 GROWING BURDEN OF CHRONIC AND ACUTE DISEASES AND ADVANCEMENTS IN POINT-OF-CARE DIAGNOSTICS TO DRIVE MARKET 51
FIGURE 18 CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 52
FIGURE 19 POINT-OF-CARE TESTING SEGMENT TO DOMINATE MARKET
DURING FORECAST PERIOD 52
FIGURE 20 ARTERIAL BLOOD SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 53
FIGURE 21 CRITICAL CARE MANAGEMENT SEGMENT TO DOMINATE
MARKET DURING FORECAST PERIOD 53
FIGURE 22 HOSPITALS & ASCS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 54
FIGURE 23 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN BLOOD
GAS ANALYZERS MARKET DURING FORECAST PERIOD 54
FIGURE 24 BLOOD GAS ANALYZERS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 55
FIGURE 25 PATENT ANALYSIS FOR BLOOD GAS ANALYZERS
(JANUARY 2014–DECEMBER 2024) 64
FIGURE 26 VALUE CHAIN ANALYSIS OF BLOOD GAS ANALYZERS MARKET: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES 66
FIGURE 27 BLOOD GAS ANALYZERS MARKET: SUPPLY CHAIN ANALYSIS 68
FIGURE 28 BLOOD GAS ANALYZERS MARKET: ECOSYSTEM ANALYSIS 70
FIGURE 29 BLOOD GAS ANALYZERS MARKET: PORTER’S FIVE FORCES ANALYSIS 72
FIGURE 30 BLOOD GAS ANALYZERS MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BLOOD GAS ANALYZERS 83
FIGURE 32 KEY BUYING CRITERIA FOR BLOOD GAS ANALYZERS 83
FIGURE 33 NUMBER OF DEALS & FUNDING ACTIVITIES IN BLOOD
GAS ANALYZERS MARKET (2021–2024) 84
FIGURE 34 MARKET POTENTIAL OF AI IN BLOOD GAS ANALYZERS MARKET 87
FIGURE 35 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET SNAPSHOT 151
FIGURE 36 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET SNAPSHOT 178
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN BLOOD GAS ANALYZERS MARKET
(2020–2024) 214
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BLOOD
GAS ANALYZERS MARKET (2024) 215
FIGURE 39 BLOOD GAS ANALYZERS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 218
FIGURE 40 BLOOD GAS ANALYZERS MARKET: COMPANY FOOTPRINT 219
FIGURE 41 BLOOD GAS ANALYZERS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 223
FIGURE 42 EV/EBITDA OF KEY VENDORS 225
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 226
FIGURE 44 BLOOD GAS ANALYZERS MARKET: BRAND COMPARISON FOR ANALYZERS 226
FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 231
FIGURE 46 WERFEN S.A: COMPANY SNAPSHOT (2024) 235
FIGURE 47 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 239
FIGURE 48 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024) 243
FIGURE 49 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024) 246
FIGURE 50 TECHNO MEDICA CO., LTD.: COMPANY SNAPSHOT (2025) 252
FIGURE 51 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 255
FIGURE 52 I-SENS, INC.: COMPANY SNAPSHOT (2024) 256
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11